Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...
The preimplantation genetic testing market is projected to surge from USD 690.2 million in 2025 to USD 1.13 billion by 2030, reflecting a robust CAGR of 10.5%. Key growth drivers include rising ...
LOS ANGELES--(BUSINESS WIRE)--DeciBio Consulting LLC’s latest market report, “Global Clinical Oncology Biomarker Testing Market Report, Second Edition: 2023-2028,” states that the global clinical ...
Magnis BR outperforms existing NGS automation solutions in throughput scalability and level of automation in the testing process. This instrument is expected to bring high-quality, standardized ...
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, ...
"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results